Market Outlook: EXAS, PCOR, GAMB, GENI, NEE, VVV - Unveiling Potential Upsides
- June 25th, 2023
- 367 views
Exact Sciences Corporation (Nasdaq: EXAS) was maintained with a Buy rating by Canaccord Genuity, who raised the price target from $92 to $115.
On Friday, $EXAS closed at $92.62, indicating a potential upside of $22.38 or 24.16% based on the financial services firm's assessment.
Procore Technologies, Inc. (NYSE: PCOR) was maintained with a Buy rating by DA Davidson, who raised the price target from $72 to $75.
Despite closing at $63.08 on Friday, the adjusted price target suggests a potential upside of $11.92 or 18.88% for $PCOR, according to the brokerage firm's analysis.
Gambling.com Group Limited (Nasdaq: GAMB), a leading provider of digital marketing services for the global online gambling industry, was initiated with a Buy rating and a price target of $13 by BTIG.
With $GAMB closing at $9.87 on Friday, the initiation price target implies a potential upside of $3.13 or 31.70% according to the financial services firm's evaluation.
Genius Sports Limited (NYSE: GENI), a leading provider of sports data and technology services, was maintained with a Buy rating by Citigroup, who raised the price target from $6 to $7.
Despite closing at $5.87 on Friday, the adjusted price target suggests a potential upside of $1.13 or 19.25% for $GENI, based on the investment firm's assessment.
NextEra Energy, Inc. (NYSE: NEE) was maintained with an Overweight rating by Morgan Stanley, who raised the price target from $92 to $93.
On Friday, $NEE closed at $74.17, indicating a potential upside of $18.83 or 25.40%, according to the global financial services firm's outlook.
Valvoline Inc. (NYSE: VVV), a leading provider of automotive services and lubricants, received an initiation of coverage with an Overweight rating and a price target of $43 from Stephens & Co.
Based on Friday's closing price of $36.06, the initiation price target suggests a potential upside of $6.94 or 19.22% for $VVV, according to the investment banking firm's evaluation.
Please note that the potential upsides mentioned for these companies are based on the assessments and recommendations of the respective brokerage firms, investment firms, or analysts, reflecting their outlook on the future performance of each company. It is important for investors to conduct their own research and consider other factors before making any investment decisions.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Tags
Post Your Comments
Want To Find Some News?
Recent Posts
-
December 05th, 2025
FDA Approves Nerve Scaffold for the Treatment of Sensory Nerve Discontinuity
December 04th, 2025December 02nd, 2025Earnings Countdown: Salesforce, Snowflake, and Guidewire Take Center Stage
November 30th, 2025Wall Street Eyes CrowdStrike, Marvell Technology, and GitLab as Earnings Near
November 30th, 2025




Member Login